Cargando…

DEXAMETHASONE–CYCLOPHOSPHAMIDE PULSE THERAPY IN PROGRESSIVE SYSTEMIC SCLEROSIS

Detalles Bibliográficos
Autores principales:	Viswanath, Vishalakshi, Sonavane, Amey D, Doshi, Aditi C, Parab, Mrunal G
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965931/ https://www.ncbi.nlm.nih.gov/pubmed/21063537 http://dx.doi.org/10.4103/0019-5154.70697

Ejemplares similares

Dexamethasone- cyclophosphamide pulse in collagen vascular diseases: An observation
por: Das, Sudip, et al.
Publicado: (2011)

Peyronie's Disease Treated with Oral Weekly Dexamethasone and Continuous Low-dose Cyclophosphamide
por: Gupta, Ramji, et al.
Publicado: (2014)

Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
por: Andersen, Kristian T., et al.
Publicado: (2020)

Degos Disease: A Murderous Menace
por: Viswanath, Vishalakshi, et al.
Publicado: (2016)

A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)
por: Chen, Yunxin, et al.
Publicado: (2021)

Systemic Sclerosis: Current Concepts in Pathogenesis and Therapeutic Aspects of Dermatological Manifestations
por: Viswanath, Vishalakshi, et al.
Publicado: (2013)

Dexamethasone-cyclophosphamide pulse therapy outcomes comparing pemphigus vulgaris and pemphigus foliaceus groups in a Brazilian cohort study()
por: Fontenelle, Ludmilla Figueiredo, et al.
Publicado: (2023)

Folliculocystic and Collagenous Hamartoma: A Rare Cutaneous Manifestation of Tuberous Sclerosis
por: Shajil, Chandana, et al.
Publicado: (2022)

Alternatives for erroneous finger probe pulse oximetry in systemic sclerosis patients during COVID-19 pandemic
por: Pathania, Yashdeep Singh
Publicado: (2021)

DEXAMETHASONE PULSE THERAPY IN PATIENTS OF SYSTEMIC SCLEROSIS: IS IT A VIABLE PROPOSITION? A STUDY FROM KASHMIR
por: Sameem, Farah, et al.
Publicado: (2010)

Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease: A Long Term Study
por: Simeón-Aznar, C.P, et al.
Publicado: (2008)

Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis
por: Kersten, Brigit E, et al.
Publicado: (2020)

Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis
por: Kersten, Brigit E, et al.
Publicado: (2020)

Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma
por: Sidana, Surbhi, et al.
Publicado: (2023)

INCREASED INCIDENCE OF TUBERCULOSIS IN PATIENTS OF SYSTEMIC SCLEROSIS ON DEXAMETHASONE PULSE THERAPY: A SHORT COMMUNICATION FROM KASHMIR
por: Ahmad, Qazi Masood, et al.
Publicado: (2008)

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011)

A Comparative Study to Evaluate the Efficacy and Cost of Rituximab versus Dexamethasone Cyclophosphamide Pulse in Patients of Pemphigus Vulgaris
por: Das, Sudip, et al.
Publicado: (2021)

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
por: Crusoe, Edvan De Queiroz, et al.
Publicado: (2020)

Dexamethasone in community-acquired pneumonia
por: Lee, Nelson, et al.
Publicado: (2011)

Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis
por: Brennan, Xavier, et al.
Publicado: (2022)

Organization of Chemotherapy and Systemic Therapy Services in India: The Devil Lies in the Details
por: Rastogi, Sameer, et al.
Publicado: (2016)

Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy
por: Venkatesh, Pradeep, et al.
Publicado: (2015)

Pulse dexamethasone therapy versus pulse methylprednisolone therapy for treatment of Graves's ophthalmopathy
por: Philip, Rajeev, et al.
Publicado: (2013)

A Case of Localized Papular Mucinosis Showing Excellent Response to Cyclophosphamide
por: Sa, Dilip K, et al.
Publicado: (2014)

Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
por: Mohty, Mohamad, et al.
Publicado: (2020)

Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
por: Dickinson, P D, et al.
Publicado: (2012)

Is there still a role for cyclophosphamide in the treatment of systemic sclerosis?
por: Vonk, Madelon C
Publicado: (2020)

Pulse cyclophosphamide therapy for steroid-resistant focal segmental glomerulosclerosis in children
por: Al Salloum, Abdullah A.
Publicado: (2004)

Whole Exome Sequencing Among 26 Patients With Indeterminate Acute Liver Failure: Response to Letter to the Editor
por: Rakela, Jorge, et al.
Publicado: (2020)

SEVERE CHRONIC URTICARIA TREATED WITH ORAL MINI-PULSE STEROID THERAPY
por: Godse, Kiran V
Publicado: (2010)

Management of Anterior Chamber Migration of Dexamethasone Intravitreal Implant
por: Ha, Jun Young, et al.
Publicado: (2017)

Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
por: Sivaraj, Dharshan, et al.
Publicado: (2018)

Central Serous Chorioretinopathy Following Intravitreal Dexamethasone Implant
por: Noh, Gwang Myeong, et al.
Publicado: (2019)

Beyond fludarabine: pentostatin plus cyclophosphamide are a well-tolerated alternative in reduced intensity conditioning
por: Dimitrova, Dimana, et al.
Publicado: (2022)

Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
por: van den Hombergh, W. M. T., et al.
Publicado: (2018)

Pulse Diagnosis
por: Kewalram, B. I.
Publicado: (1926)

Robust COVID-19 vaccination response after allogeneic stem cell transplantation using post transplantation cyclophosphamide conditioning
por: Morsink, L. M., et al.
Publicado: (2022)

Case report: Cyclophosphamide pulse therapy for chronic recalcitrant erythema nodosum leprosum
por: Machado, Gustavo U., et al.
Publicado: (2023)

Reply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate
por: Khan, O A, et al.
Publicado: (2012)

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM
por: Park, Hyunkyung, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kk7102o8uiv7pudarcn33aubvu